Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Evidence for vesicle-mediated antigen export by the human pathogen Babesia microti.

Thekkiniath J, Kilian N, Lawres L, Gewirtz MA, Graham MM, Liu X, Ledizet M, Ben Mamoun C.

Life Sci Alliance. 2019 Jun 13;2(3). pii: e201900382. doi: 10.26508/lsa.201900382. Print 2019 Jun.

2.

Direct Diagnostic Tests for Lyme Disease.

Schutzer SE, Body BA, Boyle J, Branson BM, Dattwyler RJ, Fikrig E, Gerald NJ, Gomes-Solecki M, Kintrup M, Ledizet M, Levin AE, Lewinski M, Liotta LA, Marques A, Mead PS, Mongodin EF, Pillai S, Rao P, Robinson WH, Roth KM, Schriefer ME, Slezak T, Snyder JL, Steere AC, Witkowski J, Wong SJ, Branda JA.

Clin Infect Dis. 2019 Mar 5;68(6):1052-1057. doi: 10.1093/cid/ciy614.

PMID:
30307486
3.

BmGPAC, an Antigen Capture Assay for Detection of Active Babesia microti Infection.

Thekkiniath J, Mootien S, Lawres L, Perrin BA, Gewirtz M, Krause PJ, Williams S, Doggett JS, Ledizet M, Ben Mamoun C.

J Clin Microbiol. 2018 Sep 25;56(10). pii: e00067-18. doi: 10.1128/JCM.00067-18. Print 2018 Oct.

4.

Development of Zika Virus Serological Testing Strategies in New York State.

Lee WT, Wong SJ, Kulas KE, Dupuis AP 2nd, Payne AF, Kramer LD, Dean AB, St George K, White JL, Sommer JN, Ledizet M, Limberger RJ.

J Clin Microbiol. 2018 Feb 22;56(3). pii: e01591-17. doi: 10.1128/JCM.01591-17. Print 2018 Mar.

5.

Advances in Serodiagnostic Testing for Lyme Disease Are at Hand.

Branda JA, Body BA, Boyle J, Branson BM, Dattwyler RJ, Fikrig E, Gerald NJ, Gomes-Solecki M, Kintrup M, Ledizet M, Levin AE, Lewinski M, Liotta LA, Marques A, Mead PS, Mongodin EF, Pillai S, Rao P, Robinson WH, Roth KM, Schriefer ME, Slezak T, Snyder J, Steere AC, Witkowski J, Wong SJ, Schutzer SE.

Clin Infect Dis. 2018 Mar 19;66(7):1133-1139. doi: 10.1093/cid/cix943.

6.

Coordination of different ligands to copper(II) and cobalt(III) metal centers enhances Zika virus and dengue virus loads in both arthropod cells and human keratinocytes.

Dutta S, Celestine MJ, Khanal S, Huddleston A, Simms C, Arca JF, Mitra A, Heller L, Kraj PJ, Ledizet M, Anderson JF, Neelakanta G, Holder AA, Sultana H.

Biochim Biophys Acta Gen Subj. 2018 Jan;1862(1):40-50. doi: 10.1016/j.bbagen.2017.10.004. Epub 2017 Oct 13.

PMID:
29030319
7.

Dengue Virus Infection of Aedes aegypti Requires a Putative Cysteine Rich Venom Protein.

Londono-Renteria B, Troupin A, Conway MJ, Vesely D, Ledizet M, Roundy CM, Cloherty E, Jameson S, Vanlandingham D, Higgs S, Fikrig E, Colpitts TM.

PLoS Pathog. 2015 Oct 22;11(10):e1005202. doi: 10.1371/journal.ppat.1005202. eCollection 2015 Oct.

8.

Efficient Detection of Pathogenic Leptospires Using 16S Ribosomal RNA.

Backstedt BT, Buyuktanir O, Lindow J, Wunder EA Jr, Reis MG, Usmani-Brown S, Ledizet M, Ko A, Pal U.

PLoS One. 2015 Jun 19;10(6):e0128913. doi: 10.1371/journal.pone.0128913. eCollection 2015.

9.

β cell death and dysfunction during type 1 diabetes development in at-risk individuals.

Herold KC, Usmani-Brown S, Ghazi T, Lebastchi J, Beam CA, Bellin MD, Ledizet M, Sosenko JM, Krischer JP, Palmer JP; Type 1 Diabetes TrialNet Study Group.

J Clin Invest. 2015 Mar 2;125(3):1163-73. doi: 10.1172/JCI78142. Epub 2015 Feb 2.

10.

Structural and biochemical analyses of alanine racemase from the multidrug-resistant Clostridium difficile strain 630.

Asojo OA, Nelson SK, Mootien S, Lee Y, Rezende WC, Hyman DA, Matsumoto MM, Reiling S, Kelleher A, Ledizet M, Koski RA, Anthony KG.

Acta Crystallogr D Biol Crystallogr. 2014 Jul;70(Pt 7):1922-33. doi: 10.1107/S1399004714009419. Epub 2014 Jun 29.

11.

Analysis of β-cell death in type 1 diabetes by droplet digital PCR.

Usmani-Brown S, Lebastchi J, Steck AK, Beam C, Herold KC, Ledizet M.

Endocrinology. 2014 Sep;155(9):3694-8. doi: 10.1210/en.2014-1150. Epub 2014 Jul 8.

12.

Characterization of Ixophilin, a thrombin inhibitor from the gut of Ixodes scapularis.

Narasimhan S, Perez O, Mootien S, DePonte K, Koski RA, Fikrig E, Ledizet M.

PLoS One. 2013 Jul 9;8(7):e68012. doi: 10.1371/journal.pone.0068012. Print 2013.

13.

Inhibition of mycobacterial alanine racemase activity and growth by thiadiazolidinones.

Lee Y, Mootien S, Shoen C, Destefano M, Cirillo P, Asojo OA, Yeung KR, Ledizet M, Cynamon MH, Aristoff PA, Koski RA, Kaplan PA, Anthony KG.

Biochem Pharmacol. 2013 Jul 15;86(2):222-30. doi: 10.1016/j.bcp.2013.05.004. Epub 2013 May 13.

14.

The ability of virulence factor expression by Pseudomonas aeruginosa to predict clinical disease in hospitalized patients.

Ledizet M, Murray TS, Puttagunta S, Slade MD, Quagliarello VJ, Kazmierczak BI.

PLoS One. 2012;7(11):e49578. doi: 10.1371/journal.pone.0049578. Epub 2012 Nov 12.

15.

A novel allosteric inhibitor of macrophage migration inhibitory factor (MIF).

Bai F, Asojo OA, Cirillo P, Ciustea M, Ledizet M, Aristoff PA, Leng L, Koski RA, Powell TJ, Bucala R, Anthony KG.

J Biol Chem. 2012 Aug 31;287(36):30653-63. doi: 10.1074/jbc.M112.385583. Epub 2012 Jul 10.

16.

Thiadiazolidinones: a new class of alanine racemase inhibitors with antimicrobial activity against methicillin-resistant Staphylococcus aureus.

Ciustea M, Mootien S, Rosato AE, Perez O, Cirillo P, Yeung KR, Ledizet M, Cynamon MH, Aristoff PA, Koski RA, Kaplan PA, Anthony KG.

Biochem Pharmacol. 2012 Feb 1;83(3):368-77. doi: 10.1016/j.bcp.2011.11.021. Epub 2011 Nov 29.

17.

TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis.

Demento SL, Bonafé N, Cui W, Kaech SM, Caplan MJ, Fikrig E, Ledizet M, Fahmy TM.

J Immunol. 2010 Sep 1;185(5):2989-97. doi: 10.4049/jimmunol.1000768. Epub 2010 Jul 26.

18.

Swarming motility, secretion of type 3 effectors and biofilm formation phenotypes exhibited within a large cohort of Pseudomonas aeruginosa clinical isolates.

Murray TS, Ledizet M, Kazmierczak BI.

J Med Microbiol. 2010 May;59(Pt 5):511-20. doi: 10.1099/jmm.0.017715-0. Epub 2010 Jan 21.

19.

Fusion loop peptide of the West Nile virus envelope protein is essential for pathogenesis and is recognized by a therapeutic cross-reactive human monoclonal antibody.

Sultana H, Foellmer HG, Neelakanta G, Oliphant T, Engle M, Ledizet M, Krishnan MN, Bonafé N, Anthony KG, Marasco WA, Kaplan P, Montgomery RR, Diamond MS, Koski RA, Fikrig E.

J Immunol. 2009 Jul 1;183(1):650-60. doi: 10.4049/jimmunol.0900093. Epub 2009 Jun 17.

20.

Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy.

Demento SL, Eisenbarth SC, Foellmer HG, Platt C, Caplan MJ, Mark Saltzman W, Mellman I, Ledizet M, Fikrig E, Flavell RA, Fahmy TM.

Vaccine. 2009 May 18;27(23):3013-21. doi: 10.1016/j.vaccine.2009.03.034. Epub 2009 Apr 3.

21.

Crystal structure of dengue virus type 1 envelope protein in the postfusion conformation and its implications for membrane fusion.

Nayak V, Dessau M, Kucera K, Anthony K, Ledizet M, Modis Y.

J Virol. 2009 May;83(9):4338-44. doi: 10.1128/JVI.02574-08. Epub 2009 Feb 25.

22.

A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells.

Bonafé N, Rininger JA, Chubet RG, Foellmer HG, Fader S, Anderson JF, Bushmich SL, Anthony K, Ledizet M, Fikrig E, Koski RA, Kaplan P.

Vaccine. 2009 Jan 7;27(2):213-22. doi: 10.1016/j.vaccine.2008.10.046. Epub 2008 Nov 7.

23.

Serum antibodies to West Nile virus in naturally exposed and vaccinated horses.

Magnarelli LA, Bushmich SL, Anderson JF, Ledizet M, Koski RA.

J Med Microbiol. 2008 Sep;57(Pt 9):1087-93. doi: 10.1099/jmm.0.47849-0.

24.

Antibodies targeting linear determinants of the envelope protein protect mice against West Nile virus.

Ledizet M, Kar K, Foellmer HG, Bonafé N, Anthony KG, Gould LH, Bushmich SL, Fikrig E, Koski RA.

J Infect Dis. 2007 Dec 15;196(12):1741-8. doi: 10.1086/523654.

PMID:
18190253
25.

West Nile virus envelope protein inhibits dsRNA-induced innate immune responses.

Arjona A, Ledizet M, Anthony K, Bonafé N, Modis Y, Town T, Fikrig E.

J Immunol. 2007 Dec 15;179(12):8403-9.

26.

Antiviral peptides targeting the west nile virus envelope protein.

Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E.

J Virol. 2007 Feb;81(4):2047-55. Epub 2006 Dec 6.

27.

Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes.

Kanai R, Kar K, Anthony K, Gould LH, Ledizet M, Fikrig E, Marasco WA, Koski RA, Modis Y.

J Virol. 2006 Nov;80(22):11000-8. Epub 2006 Aug 30.

28.

Detection of antibodies to West Nile virus in equine sera using microsphere immunoassay.

Balasuriya UB, Shi PY, Wong SJ, Demarest VL, Gardner IA, Hullinger PJ, Ferraro GL, Boone JD, De Cino CL, Glaser AL, Renshaw RW, Ledizet M, Koski RA, MacLachlan NJ.

J Vet Diagn Invest. 2006 Jul;18(4):392-5.

PMID:
16921881
29.

Gamma delta T cells facilitate adaptive immunity against West Nile virus infection in mice.

Wang T, Gao Y, Scully E, Davis CT, Anderson JF, Welte T, Ledizet M, Koski R, Madri JA, Barrett A, Yin Z, Craft J, Fikrig E.

J Immunol. 2006 Aug 1;177(3):1825-32.

30.
31.

Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus.

Gould LH, Sui J, Foellmer H, Oliphant T, Wang T, Ledizet M, Murakami A, Noonan K, Lambeth C, Kar K, Anderson JF, de Silva AM, Diamond MS, Koski RA, Marasco WA, Fikrig E.

J Virol. 2005 Dec;79(23):14606-13.

32.

A recombinant envelope protein vaccine against West Nile virus.

Ledizet M, Kar K, Foellmer HG, Wang T, Bushmich SL, Anderson JF, Fikrig E, Koski RA.

Vaccine. 2005 Jun 10;23(30):3915-24. Epub 2005 Apr 6.

PMID:
15917113
33.

Discovery and pre-clinical development of antithrombotics from hematophagous invertebrates.

Ledizet M, Harrison LM, Koskia RA, Cappello M.

Curr Med Chem Cardiovasc Hematol Agents. 2005 Jan;3(1):1-10. Review.

PMID:
15638739
34.

Detection of human anti-flavivirus antibodies with a west nile virus recombinant antigen microsphere immunoassay.

Wong SJ, Demarest VL, Boyle RH, Wang T, Ledizet M, Kar K, Kramer LD, Fikrig E, Koski RA.

J Clin Microbiol. 2004 Jan;42(1):65-72.

35.

Differential regulation of centrin genes during ciliogenesis in human tracheal epithelial cells.

LeDizet M, Beck JC, Finkbeiner WE.

Am J Physiol. 1998 Dec;275(6):L1145-56. doi: 10.1152/ajplung.1998.275.6.L1145.

PMID:
9843852
36.

Fission yeast pkl1 is a kinesin-related protein involved in mitotic spindle function.

Pidoux AL, LeDizet M, Cande WZ.

Mol Biol Cell. 1996 Oct;7(10):1639-55.

38.
39.
40.

Detection of acetylated alpha-tubulin by specific antibodies.

LeDizet M, Piperno G.

Methods Enzymol. 1991;196:264-74. No abstract available.

PMID:
2034123
41.

Identification of an acetylation site of Chlamydomonas alpha-tubulin.

LeDizet M, Piperno G.

Proc Natl Acad Sci U S A. 1987 Aug;84(16):5720-4.

42.

Microtubules containing acetylated alpha-tubulin in mammalian cells in culture.

Piperno G, LeDizet M, Chang XJ.

J Cell Biol. 1987 Feb;104(2):289-302.

Supplemental Content

Loading ...
Support Center